Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

brain metastasis

  • Hybrid <sup>18</sup>F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
    Open Access
    Hybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
    Nathaniel J. Smith, Tristan K. Deaton, Wendy Territo, Brian Graner, Andrew Gauger, Scott E. Snyder, Michael L. Schulte, Mark A. Green, Gary D. Hutchins and Michael C. Veronesi
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.122.265149
  • <sup>18</sup>F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
    Open Access
    18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
    Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries and Geke A.P. Hospers
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 899-905; DOI: https://doi.org/10.2967/jnumed.121.262368
  • You have access
    18F-FET PET Uptake Characteristics in Patients with Newly Diagnosed and Untreated Brain Metastasis
    Marcus Unterrainer, Norbert Galldiks, Bogdana Suchorska, Lara-Caroline Kowalew, Vera Wenter, Christine Schmid-Tannwald, Maximilian Niyazi, Peter Bartenstein, Karl-Josef Langen and Nathalie L. Albert
    Journal of Nuclear Medicine April 1, 2017, 58 (4) 584-589; DOI: https://doi.org/10.2967/jnumed.116.180075
  • You have access
    Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts
    Sharon K. Michelhaugh, Otto Muzik, Anthony R. Guastella, Neil V. Klinger, Lisa A. Polin, Hancheng Cai, Yangchun Xin, Thomas J. Mangner, Shaohui Zhang, Csaba Juhász and Sandeep Mittal
    Journal of Nuclear Medicine February 1, 2017, 58 (2) 208-213; DOI: https://doi.org/10.2967/jnumed.116.179994
  • You have access
    Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates
    Nicolas Tournier, Sebastien Goutal, Sylvain Auvity, Alexander Traxl, Severin Mairinger, Thomas Wanek, Ourkia-Badia Helal, Irène Buvat, Michael Soussan, Fabien Caillé and Oliver Langer
    Journal of Nuclear Medicine January 1, 2017, 58 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.116.178665
SNMMI

© 2025 SNMMI

Powered by HighWire